Personal information

Verified email domains

Biography

Dr. Ling Peng is currently a research director at the French National Scientific Research Center (CNRS) and working in the Centre Interdisciplinaire de Nanoscience de Marseille (CINaM), France. After obtaining her undergraduate degree in polymer chemistry from Nanjing University in China, she carried out her PhD program in organic synthesis under the supervision of Prof Albert Eschenmoser at the Swiss Federal Institute of Technology in Zurich (ETH), Switzerland. She then moved to the Louis Pasteur University of Strasbourg in France to join Prof Maurice Goeldner’s group for a post-doctoral research position in pharmacy. In 1997, she was recruited as a research scientist by the CNRS, before being promoted to research director in 2008, then 1st class Research Director in 2015 and exceptional class Research Director in 2023.
Dr. PENG has been working actively at the interface of chemistry and biology, in particular developing functional dendrimers for biomedical applications, molecular probes for exploring biological events and nucleoside analogues for drug discovery. She has established bio-inspired, structurally flexible dendrimers for nucleic acid delivery. Dr Peng has inaugurated and pioneered the concept of non-covalently constructing supramolecular dendrimers by self-assembly of small amphiphilic dendrimer building units for biomedical applications. Her team has created various self-assembling supramolecular dendrimers of different sizes, shapes and properties for specific biomedical applications, such as the delivery of anticancer drugs and nucleic acid therapeutics for cancer treatment, gene therapy and immunotherapy, and imaging agents for diagnosis. For the great and innovative contributions in the use of dendrimers in cancer therapy and imaging, her team has been selected and supported by the largest French cancer foundation “La Ligue contre le Cancer” for priority funding since 2016.
Dr. Peng is the Distinguished Member of the French Chemical Society. Based on her highly inspiring and outstanding research, she was awarded the Dr and Mme Henri Labbé prize from the French Academy of Sciences in 2017, the Grand Prize of the French Chemical Society SUD PACA and the André Collet Prize of Supramolecular Chemistry by the French Chemical Society in 2024.

Activities

Employment (2)

CNRS: Marseille, Provence-Alpes-Côte d'Azu, FR

2008-10-01 to present | Research Director (Centre Interdisciplinaire de Nanoscience de Marseille)
Employment
Source: Self-asserted source
Ling PENG

CNRS: Marseille, ---, FR

1999-12-01 to present | CNRS principal investigator
Employment
Source: Self-asserted source
Ling PENG

Education and qualifications (2)

Swiss Federal Institute of Technology : Zurich, Zurich, CH

1987-11-01 to 1993-01-30 | Ph.D (Natural Sciences)
Education
Source: Self-asserted source
Ling PENG

Nanjing University: Nanjing, Jiangsu, CN

1982-09-01 to 1986-06-01 | Bachelor (Chemistry)
Education
Source: Self-asserted source
Ling PENG

Professional activities (7)

Société de Chimie Thérapeutique: Chatenay-Malabry, FR

Membership
Source: Self-asserted source
Ling PENG

Royal Society of Chemistry: London, London, GB

Membership
Source: Self-asserted source
Ling PENG

China Pharmaceutical University: Nanjing, Jiangsu, CN

visiting professor
Invited position
Source: Self-asserted source
Ling PENG

Société Chimiqe de France: MARSEILLE, Bouches-du-Rhône, FR

2003 to present
Membership
Source: Self-asserted source
Ling PENG

French Chemical Society: Marseille, Provence-Alpes-Côte d'Azur, FR

2024 | Le Grand Prix SCF SUD PACA (SCF SUD PACA)
Distinction
Source: Self-asserted source
Ling PENG

French Academy of Sciences: Paris, FR

2017 | Prize of Dr and Mrs Henri Labbé
Distinction
Source: Self-asserted source
Ling PENG

French Society of Photobiology: Paris, FR

1996 | Roussel Prize
Distinction
Source: Self-asserted source
Ling PENG

Funding (9)

Oligonucleotides for Medical Applications (OLIGOMED)

2021 to 2024 | Grant
EU (Brusselle, BE)
Source: Self-asserted source
Ling PENG

Modular nanosystems for multimodal imaging and theranostics to fight against cancer

2021 to 2023 | Grant
Ligue Contre le Cancer (Paris, FR)
GRANT_NUMBER:

EL2021.LNCC/LPP

Source: Self-asserted source
Ling PENG
grade
Preferred source (of 2)‎

Reactivation of antitumor immune responses in gliomas using nanotechnology based targeted delivery (iNanoGun)

2021 to 2023 | Grant
Agence Nationale de la Recherche (Marseille, FR)
Part of GRANT_NUMBER:

ANR-20-ENM3-0004-03

Source: Self-asserted source
Ling PENG

Development of CXCR4 targeting -nanosystem-imaging probes for molecular imaging of cancer cells and tumor microenvironment (NAN-4-TUM)

2020 to 2023 | Grant
Agence Nationale de la Recherche (Marseille, FR)
Part of GRANT_NUMBER:

ANR-19-ENM3-0004-03

Source: Self-asserted source
Ling PENG

Safety testing in the life cycle of nanotechnology-enabled medical technologies for health (SAFE-N-MEDTECH)

2019-04 to 2023-03 | Grant
European Commission (Marseille, FR)
Part of GRANT_NUMBER:

SAFE-N-MEDTECH

Source: Self-asserted source
Ling PENG

Nanosystems conjugated with antibody fragments for treating brain infections

2019-03 to 2022-02 | Grant
Agence Nationale de la Recherche (Paris, FR)
GRANT_NUMBER:

ANR-18-ENM3-0005-03

Source: Self-asserted source
Ling PENG

Nanotechnology based immunotherapy for glioblastoma

2017-03 to 2020-02 | Grant
Agence Nationale de la Recherche (Paris, FR)
GRANT_NUMBER: ANR-16-ENM2-0004-02
Source: Self-asserted source
Ling PENG

(Nano) systems with active targeting to sensitize colorectal cancer stem cells to anti-tumoral treatment

2016-03 to 2019-02 | Grant
Agence Nationale de la Recherche (Paris, FR)
GRANT_NUMBER:

ANR-2015-ENM2-0006-02

Source: Self-asserted source
Ling PENG

Innovative dendrimer nanotechnology based theranostics for cancer therapy

2016-01 to 2020-12 | Grant
Ligue Contre le Cancer (Paris, FR)
GRANT_NUMBER:

N° EL2016.LNCC/LPP

Source: Self-asserted source
Ling PENG

Peer review (8 reviews for 6 publications/grants)

Review activity for ACS applied materials & interfaces. (1)
Review activity for Biomacromolecules. (2)
Review activity for Chemical reviews. (1)
Review activity for Chemistry of materials. (1)
Review activity for Journal of the American Chemical Society. (2)
Review activity for Molecular pharmaceutics. (1)